Jonathan Grivel

878 total citations
9 papers, 171 citations indexed

About

Jonathan Grivel is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Jonathan Grivel has authored 9 papers receiving a total of 171 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Immunology. Recurrent topics in Jonathan Grivel's work include Cancer Immunotherapy and Biomarkers (8 papers), Lung Cancer Treatments and Mutations (4 papers) and Lung Cancer Research Studies (3 papers). Jonathan Grivel is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Lung Cancer Treatments and Mutations (4 papers) and Lung Cancer Research Studies (3 papers). Jonathan Grivel collaborates with scholars based in France, Spain and Italy. Jonathan Grivel's co-authors include Lisa Boselli, Lydie Cassard, Nathalie Chaput, Benjamin Besse, Marie Naigeon, Édouard Auclin, Aude Desnoyer, Boris Duchemann, Laura Mezquita and Karim El Soufi and has published in prestigious journals such as Annals of Oncology, European Journal of Cancer and Cancers.

In The Last Decade

Jonathan Grivel

9 papers receiving 169 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan Grivel France 7 114 60 55 45 22 9 171
Yusuke Nakamura United States 4 195 1.7× 76 1.3× 38 0.7× 57 1.3× 18 0.8× 5 260
Mario Sznol United States 9 135 1.2× 96 1.6× 45 0.8× 41 0.9× 14 0.6× 21 187
Cathy Schilero United States 6 57 0.5× 34 0.6× 36 0.7× 33 0.7× 21 1.0× 13 113
Ian Lewis United Kingdom 6 57 0.5× 31 0.5× 23 0.4× 50 1.1× 28 1.3× 11 141
Kristof Cuppens Belgium 8 94 0.8× 40 0.7× 80 1.5× 44 1.0× 32 1.5× 28 155
Marie Naigeon France 9 163 1.4× 78 1.3× 86 1.6× 34 0.8× 26 1.2× 21 212
Anne Sibille Belgium 9 137 1.2× 28 0.5× 83 1.5× 53 1.2× 13 0.6× 21 204
Robert A. Belderbos Netherlands 7 136 1.2× 68 1.1× 156 2.8× 39 0.9× 52 2.4× 14 283
Masayuki Shirasawa Japan 10 167 1.5× 24 0.4× 108 2.0× 27 0.6× 21 1.0× 25 213

Countries citing papers authored by Jonathan Grivel

Since Specialization
Citations

This map shows the geographic impact of Jonathan Grivel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Grivel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Grivel more than expected).

Fields of papers citing papers by Jonathan Grivel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Grivel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Grivel. The network helps show where Jonathan Grivel may publish in the future.

Co-authorship network of co-authors of Jonathan Grivel

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Grivel. A scholar is included among the top collaborators of Jonathan Grivel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Grivel. Jonathan Grivel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Duchemann, Boris, Marie Naigeon, Édouard Auclin, et al.. (2022). CD8+PD-1+ to CD4+PD-1+ ratio (PERLS) is associated with prognosis of patients with advanced NSCLC treated with PD-(L)1 blockers. Journal for ImmunoTherapy of Cancer. 10(2). e004012–e004012. 21 indexed citations
2.
3.
Duchemann, Boris, Jordi Remón, Marie Naigeon, et al.. (2021). Current and future biomarkers for outcomes with immunotherapy in non-small cell lung cancer. Translational Lung Cancer Research. 10(6). 2937–2954. 21 indexed citations
4.
Riudavets, Mariona, Marie Naigeon, Matthieu Texier, et al.. (2021). Gefitinib plus tremelimumab combination in refractory non-small cell lung cancer patients harbouring EGFR mutations: The GEFTREM phase I trial. Lung Cancer. 166. 255–264. 15 indexed citations
5.
Duchemann, Boris, Jordi Remón, Marie Naigeon, et al.. (2020). Integrating Circulating Biomarkers in the Immune Checkpoint Inhibitor Treatment in Lung Cancer. Cancers. 12(12). 3625–3625. 28 indexed citations
6.
Mezquita, Laura, Patricia Martín-Romano, Édouard Auclin, et al.. (2019). MA07.01 Circulating Immature Neutrophils, Tumor-Associated Neutrophils and dNLR for Identification of Fast Progressors to Immunotherapy in NSCLC. Journal of Thoracic Oncology. 14(10). S272–S273. 3 indexed citations
7.
8.
Ferrara, Roberto, Marie Naigeon, Édouard Auclin, et al.. (2018). Immunosenescence (iSenescence) correlates with disease progression in advanced non-small cell lung cancer (aNSCLC) patients treated with PD-(L)1 inhibitors (IO). Annals of Oncology. 29. viii511–viii511. 7 indexed citations
9.
Pitoiset, Fabien, Lydie Cassard, Karim El Soufi, et al.. (2018). Deep phenotyping of immune cell populations by optimized and standardized flow cytometry analyses. Cytometry Part A. 93(8). 793–802. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yusuke Nakamura Breakdown of academic impact, for papers by Mario Sznol Breakdown of academic impact, for papers by Cathy Schilero Breakdown of academic impact, for papers by Ian Lewis Breakdown of academic impact, for papers by Kristof Cuppens Breakdown of academic impact, for papers by Marie Naigeon Breakdown of academic impact, for papers by Anne Sibille Breakdown of academic impact, for papers by Robert A. Belderbos Breakdown of academic impact, for papers by Masayuki Shirasawa
Rankless by CCL
2026